In comparison to placebo, liraglutide treatment reduced the prevalence of NAFLD by two-thirds, the amount of fat in the liver by 44%, visceral adipose tissue by 18%, and body weight by 5.2 kg (5.6%) (199)
Glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus regulate food intake
This article outlines the skin reactions reported to date, who may be at greater risk, how to manage symptoms effectively, when to seek medical advice, and the current MHRA regulatory position on retatrutide in the UK
Phase 3 clinical trials continue, with approval decisions expected sometime between late 2026 and early 2027
women of childbearing potential should discuss contraception with their prescriber before starting any weight-management medicine Without clinical supervision, monitoring of blood glucose, IGF-1 levels, lipid panels, and cardiovascular parameters would not be in place, significantly increasing the risk of undetected harm
GLP-1 tells your pancreas to produce insulin while stopping your body from increasing your blood sugar levels
